Industry
Featured experience
Novo Nordisk acquisition of certain Catalent sites from Novo Holdings
We are advising Novo Nordisk on the acquisition
AbbVie $15 billion senior notes offering
The investment-grade offering comprised seven tranches
Auna $360 million U.S. IPO
We advised Auna on its U.S. IPO and NYSE listing
Trial victory in patent infringement case for Magnolia Medical Technologies
We served as lead trial counsel for Magnolia Medical in an action against its sole competitor
Dynamics Special Purpose Corp. completed combination with Senti Biosciences
We advised Dynamics Special Purpose Corp. on this transaction
InSilico Medicine $60 million Series D financing
We are advising InSilico Medicine in connection with its $60 million Series D financing
Astorg acquisition of OPEN Health
We are advising Astorg on the transaction
GSK $3.3 billion acquisition of Affinivax
We are advising GSK on the acquisition
Laekna Therapeutics $61 million Series D financing
We are advising Laekna Therapeutics in connection with its Series D financing
Bausch + Lomb $630 million IPO
We are advising Bausch Health on the separation of its eye health business into a new public company, Bausch + Lomb
Anthem $1.3 billion senior notes offering
The investment-grade notes are due 2032 and 2052
Deciphera Pharmaceuticals $172.5 million stock and pre-funded warrants offering
The stock is listed on the Nasdaq Global Market
HilleVax $200 million IPO
The shares are listed on the Nasdaq Global Select Market
Acutus Medical sale of its left-heart access portfolio products
We are advising Acutus Medical on the transaction